Enzymatica in agreement for enzyme formulations for the Chinese skin care market

Enzymatica’s subsidiary Zymetech has entered a non-exlusive agreement with Dr Bragi Company Ltd for the sales and delivery of three different enzyme formulations based on Enzymatica’s patented enzyme technology, which will be used in Dr Bragi Company’s skin care products. It is a five-year agreement covering China and parts of Asia. Dr Bragi Company has placed an initial order of about SEK 0.8 million for delivery at year-end  2019. Follow-up orders are expected in 2020. The agreement of formulations based on Enzymatica’s patented enzyme technology is the second agreement, after the agreement with the German company Maren Cosmetics in June, 2019.

“Once again, our patented enzyme technology proves to be valuable also for dermal applications, not the least for such a large market as China,” says Fredrik Lindberg, CEO of Enzymatica.

For more information, please contact:

Fredrik Lindberg, CEO Enzymatica AB
Phone: +46 (0)708-86 53 70 | Email: fredrik.lindberg@enzymatica.com

Carl-Johan Wachtmeister, Communication manager Enzymatica AB
Phone: +46 (0)0701-88 50 21 | Email: carl-johan.wachtmeister@enzymatica.com

About Enzymatica AB

Enzymatica AB is a Swedish life science company that develops and sells health care products for primarily conditions of the ear-nose-and-throat region. The products are based on a barrier technology that includes marine enzymes. The company’s first product is the medical device ColdZyme®, a mouth spray against common cold. The product has been launched in about ten markets. The strategy is to continue to grow by developing more health care products and strengthening the company’s position in existing markets and expanding into new geographic markets through established partners. The company has its headquarters in Lund and is listed on Nasdaq First North Growth Market. For more information, visit: www.enzymatica.com and www.enzymatica.se/en/section/media/press-releases

Enzymatica’s certified adviser is Erik Penser Bank.Om Enzymatica AB Phone: +46 (0)8 463 83 00. Email: certifiedadviser@penser.se

 

Enzymatica AB Ideon Science Park, SE-223 70 Lund, Sweden Telefon +46 46-286 31 00

Enzymatica cares about your privacy and processes your personal data in accordance with the EU’s General Data Protection Regulation. For more information about how we handle your personal information, and what rights you have, please refer to our personal data processing document here.